Differential DNA methylation panel derived from peripheral blood could serve as biomarkers of CRC susceptibility. However, most of the previous studies utilized post-diagnostic blood DNA which may be markers of disease rather than susceptibility. | A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility